Best Conservative treatment doctors: TOP 15 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood
Carlo Meloni
  • 4.5 Good 59 reviews
  • 34 years of experience
  • Italy, Milan, San Raffaele
Doctor's visit
Price on request
Markus Düx
  • 4.4 Good 52 reviews
  • 43 years of experience
  • Germany, Frankfurt am Main, Nordwest Clinic (Krankenhaus)
Doctor's visit
Price on request
Mehmet Onur Ozturk
  • New
  • 15 years of experience
  • Turkey, İzmir, Bewell Health Assistance
Doctor's visit
Price on request
Nikolay Polischuk
  • New
  • 45 years of experience
  • Ukraine, Kyiv, Rezonans Chronomedicine Clinic
  • Nikolay Polischuk is a PhD candidate and director of the chronomedicine clinic “Resonance” in Kyiv, Ukraine.

    Education

    • Naval Faculty at the Kirov Military Medical Academy in St. Petersburg, Russia.
    • Faculty of Medicine at the Kiev Medical Institute named after A.A. Bogomolets, Ukraine.
  • Read more
Doctor's visit
Price on request
Marc Ulrich Becher
  • 4.6 Excellent 56 reviews
  • 25 years of experience
  • Germany, Solingen, Medical Center in Solingen
  • Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist. He provides operations such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty and stenting, among others.
  • Read more
Doctor's visit
Price on request
Nail Paksoy
  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Doctor's visit
Price on request

Find out about the best doctors here

20 top ranked Conservative treatment doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Conservative treatment doctors on Bookimed.com:

How to choose the best Conservative treatment doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Conservative treatment doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Conservative treatment varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Conservative treatment if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Dursun Aras
  • 5 Excellent 2 reviews
  • 29 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2019 - 2022

    University of Health Sciences, Faculty of Medicine, Ankara City Hospital, Cardiology Clinic, Ankara

    2017 - 2019

    University of Health Sciences, Faculty of Medicine, Turkey Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2012 - 2017

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2012 - 2017

    T.R. Karabük University, Faculty of Medicine, Department of Cardiology

    2006 - 2006

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2001 - 2006

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    1996 - 2001

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

     

    Education

    2017 Karabük University, Faculty of Medicine, Department of Cardiology

     

    2006 Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic

     

    2001 Türkiye Higher Specialization Training and Research Hospital, Ankara, Cardiology

     

    1996 Ankara University, Faculty of Medicine

  • Read more
Doctor's visit
Price on request
Arzu Musayeva
  • New
  • 39 years of experience
  • Azerbaijan, Baku, Biological Medicine-Integrative Health Center Baku
  • DR. Arzu Musaeva

    Education: Azerbaijan Medical University.

    Specialization: therapist

    Working hours and days: weekdays 10:00-15:00.

    Training and membership:

    16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

    02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

    improvement.

    01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

    22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

    26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

    Germany).

    12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

    23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

    28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

    13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

    14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

    Baden, Germany).

    20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

    Germany).

    27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

    02/16/2010. "Homotoxicology" Dr. Alta Smith.

    05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

    Joachim Bandlow.

    21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

    04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

    10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

    "Sharing Methods" by Dr. Jurgen Frost.

    07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

    refresher course.

    11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

    10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

    (Baden-Baden, Germany).

    12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

    05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

    Flechsig (Germany).

    10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

    12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

    01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

    05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

    06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

    04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

    21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

    31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

    10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

    12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

    Germany).

    2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

    2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

    (Switzerland).

    14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

    honey. Arturo Obirne (Colombia).

    15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

    (Baden-Baden, Germany).

    04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

    21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

    Doctor med. Siddhartha Popat (Baden-Baden, Germany).

    01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

    Preussler (Germany).

    05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

    05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

    06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

    14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

    (Colombia).

    Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

    Received the Hans-Heinrich Reckeweg Prize for clinical cases.

    Examinations and treatment performed:

    • Bioregulatory therapy of all therapeutic diseases.

    • Atherosclerosis, stenosis, occlusion of peripheral arteries.

    • Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

    • Peripheral nerve neuropathy.

    • Diabetic paw, osteoarthropathy, osteomyelitis.

    • Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

    treatment and prevention of delayed complications in the lower extremities.

    • Gangrenous pyoderma.

    • Treatment of trophic ulcers.

  • Read more
Doctor's visit
Price on request
Fedash-kirsanov Alexander Alexandrovich
  • 5 Excellent 3 reviews
  • 15 years of experience
  • Ukraine, Kyiv, Impuls Medical Center
Doctor's visit
Price on request
Tsios Yuri Anatolievich
  • 5 Excellent 3 reviews
  • 21 years of experience
  • Ukraine, Kyiv, Impuls Medical Center
Doctor's visit
Price on request
Murat Balanli
  • New
  • 37 years of experience
  • Turkey, Istanbul, BHLC Medical
  • Professional Summary

    Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.

    Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.

     

    *Educational Background

    Doctor of Medicine (MD)
    Ege University, Faculty of Medicine, 1988

    Specialist Training in Internal Medicine
    Tepecik Training and Research Hospital, 1994

    Master’s Degree in Health Institutions Management
    Başkent University, Faculty of Social Sciences, 2012

     

    *Professional Experience

    Healthy Living Clinic, Turkey

    Founder and Head Practitioner
    2014 - Present
    Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.

    SB Behçet Uz Children's Diseases and Surgery Training and Research Hospital

    Hospital Administrator
    2015 - 2018
    Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.

    Social Security Institution (SGK), Izmir

    Regional Director of Health Affairs
    2004 - 2009
    Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.

    Board Member
    2009 - 2012
    Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.

    Kayseri Ibn-i Sina Medical Centers

    Chief Physician
    2003 - 2008
    Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.

    Tokat Niksar State Hospital

    Chief Physician
    1996
    Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.

     

    *Certifications and Advanced Training

    • Neuroanatomy, Neuroelectrophysiology, and Biofeedback
      Completed in Romania
    • Biorezonance Medicine and Applications
      Completed in Russia
      Specialized training in biorezonance therapy to support holistic approaches in addressing various chronic and stress-related conditions.

    *Key Skills and Expertise

    • Internal Medicine
    • Holistic Medicine Approaches
    • Holistic Wellness Approaches
    •  
    • Patient-Centered Care
    • Biorezonance Therapy
    • Health Systems Management
    • Hospital and Healthcare Administration

    Publications and Contributions

    Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.

     

    Languages

    • Turkish (Native)
    • English (Fluent)
    • Russian (Native)
    • Azerbaijani (Fluent)
  • Read more
Doctor's visit
Price on request
Viktor Alexander Krol
  • 4 Good 1 review
  • 25 years of experience
  • Germany, Dusseldorf, St. Martinus-Krankenhaus Düsseldorf
Doctor's visit
Price on request
Nazrin Namazova
  • 4.6 Excellent 13 reviews
  • 11 years of experience
  • Azerbaijan, Baku, Liv Bona Dea Hospital Baku
Doctor's visit
Price on request
Asadulla Aghayev
  • 4.6 Excellent 13 reviews
  • 15 years of experience
  • Azerbaijan, Baku, Liv Bona Dea Hospital Baku
Doctor's visit
Price on request
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team